LEGAL & MEDICAL DISCLAIMER: The information provided on this page by PeptideMatch.io is intended solely for educational and informational purposes. It does not constitute, and should not be interpreted as, professional medical advice, diagnosis, or treatment. Always consult a licensed physician or qualified healthcare provider before beginning any peptide therapy or making changes to an existing treatment plan. PeptideMatch.io does not prescribe, dispense, or endorse any specific therapeutic protocol. Individual results may vary, and no outcomes are guaranteed.

What Is Semax?

When the brain experiences stress, whether from cognitive demands, aging, or acute injury like a stroke, it relies on a complex network of chemical signals to protect its neurons and maintain function. Researchers have spent decades looking for ways to support this natural defense system. One of the most studied compounds in this area is a synthetic neuropeptide called Semax.

Semax is a synthetic heptapeptide (a chain of seven amino acids) developed in Russia at the Institute of Molecular Genetics. It is an analog of a specific fragment of adrenocorticotropic hormone (ACTH 4-10), but with an important modification: a Pro-Gly-Pro extension was added to the chain to significantly increase its stability and prevent rapid breakdown by enzymes in the body. Its full scientific designation is ACTH(4-7)PGP.¹

What makes this neuropeptide unique is its targeted action. Unlike full-length ACTH, Semax does not stimulate the production of cortisol or other stress hormones. Instead, its primary effects appear to be neurotrophic, meaning it supports the growth, survival, and plasticity of neurons, making it a subject of intense study for both cognitive enhancement and recovery from neurological injury.²

Fast Facts

How Does Semax Work?

Think of Semax not as a direct stimulant like caffeine, but rather as a signal that tells the brain’s maintenance crew to increase production of the materials needed to keep neurons healthy and adaptable.

1. Boosting a Key Brain Growth Protein One of the most studied effects of Semax is its ability to increase levels of a protein called BDNF (Brain-Derived Neurotrophic Factor). Think of BDNF as a fertilizer for brain cells: it helps existing neurons survive and encourages the brain to form new connections. In laboratory studies, a single application of Semax was associated with a 1.4-fold increase in BDNF levels in the hippocampus, the region of the brain most closely tied to learning and memory.¹
2. Dialing Down Brain Inflammation After Injury When the brain is injured, such as during a stroke, it often triggers a wave of inflammation that can cause additional damage beyond the original injury. Researchers studying Semax found that it appears to switch off many of the genes responsible for that inflammatory response, while at the same time switching on genes involved in healthy brain signaling. In experimental stroke models, the pattern of gene activity seen after Semax was given was largely the reverse of the damage pattern caused by the stroke itself, suggesting the peptide may help the brain push back against injury.²
3. Influencing the Brain’s Chemical Messengers Semax also appears to interact with several of the brain’s key signaling chemicals. Studies have observed that it may influence serotonin activity and increase dopamine release in areas of the brain associated with motivation and focus. It has also been shown to affect the activity of GABA and glycine, two chemicals that play a role in calming neural activity. Together, these interactions may help explain the cognitive and attention-related effects observed in research.^{1, 2}

The research on Semax spans several decades, with the vast majority of clinical trials conducted in Russia, where it is an approved therapeutic agent. PeptideMatch.io presents this data to help our community understand the scope of research and the distinction between preclinical findings and confirmed human outcomes.

One clinical study published in a Russian neurology journal followed 30 patients in the early days after a stroke, comparing their recovery to 80 patients who received standard care alone. Patients who received Semax as part of their treatment showed faster recovery of brain function and greater improvement in movement and coordination compared to the standard care group.³

The most studied use of Semax is in brain injury and stroke recovery. When a stroke occurs, blood flow to part of the brain is cut off, causing brain cells to die and triggering a wave of inflammation that can extend the damage. Semax has been studied for its potential to limit that secondary damage and support the brain’s own recovery process.

While these findings are encouraging, it is worth noting that large-scale trials replicating these results under FDA or European Medicines Agency (EMA) oversight have not yet been conducted in the United States or Western Europe.^{2, 3}

Protecting the Brain After a Stroke: In experimental models, Semax was associated with changes in the activity of nearly 400 genes, shifting the brain’s environment away from inflammation and toward repair.

What Researchers Observed: In Russian clinical trials, patients who received Semax in the early days after a stroke showed better recovery of movement and coordination compared to those who received standard care alone.

Slowing Disease Progression: It has also been studied for its potential to slow the worsening of chronic conditions that reduce blood flow to the brain over time.

Cognitive Function and BDNF

Beyond stroke recovery, Semax has attracted research interest for its potential effects on everyday cognitive function, learning, and memory. Much of this interest centers on its ability to increase levels of BDNF, a protein the brain uses to maintain healthy neurons and build new connections.¹

BDNF plays a central role in how the brain learns and adapts. Higher levels of it are associated with stronger memory formation and better mental flexibility. In laboratory studies, Semax was shown to raise BDNF levels in the hippocampus, the part of the brain most involved in forming new memories. Animals in these studies also performed better on learning and memory tasks, suggesting the two findings may be directly connected.¹

Safety Profile and What to Know

In the clinical trials reviewed, including those involving patients recovering from acute strokes, Semax was generally well-tolerated. A key safety feature of this neuropeptide is that, despite being an analog of ACTH, it does not stimulate the adrenal glands to produce cortisol or other stress hormones, avoiding the systemic side effects associated with direct ACTH administration.³The peptide has a very short half-life in the bloodstream, as it is rapidly degraded by natural enzymes. Because of this, it is typically administered in ways that bypass systemic circulation to reach the brain more directly.¹

Important Considerations

Scientific References

1. Dolotov OV, Karpenko EA, Inozemtseva LS, et al. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Res. 2006;1117(1):54-60.
2. Filippenkov IB, Stavchansky VV, Denisova AE, et al. Novel Insights into the Protective Properties of ACTH(4-7)PGP (Semax) Peptide at the Transcriptome Level Following Cerebral Ischaemia-Reperfusion in Rats. Genes (Basel). 2020;11(6):681.
3. Gusev EI, Skvortsova VI, Miasoedov NF, et al. Effectiveness of semax in acute period of hemispheric ischemic stroke (a clinical and electrophysiological study). Zh Nevrol Psikhiatr Im S S Korsakova. 1997;97(6):26-34.

©2026 PeptideMatch.io. All Rights Reserved. This educational content is the exclusive intellectual property of PeptideMatch.io. Reproduction, distribution, republication, or transmission of this material, in whole or in part, in any form or by any means, is strictly prohibited without the prior written consent of PeptideMatch.io. For licensing or reprint inquiries, please contact content@peptidematch.io.